Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
30.671 (96/313) |
2.15E-28 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
29.057 (77/265) |
1.78E-26 |
MEK kinase kinase 3 (MAP4K3)
|
|
31.416 (71/226) |
1.44E-25 |
Serine/threonine-protein kinase 25 (STK25)
|
|
29.670 (81/273) |
2.76E-25 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
31.308 (67/214) |
5.87E-25 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
29.187 (61/209) |
1.06E-24 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
32.710 (70/214) |
1.11E-24 |
MEK kinase kinase 1 (MAP4K1)
|
|
32.338 (65/201) |
2.02E-24 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
32.850 (68/207) |
3.80E-24 |
Serine/threonine-protein kinase 24 (STK24)
|
|
29.044 (79/272) |
4.80E-24 |
MEK kinase kinase 2 (MAP4K2)
|
|
30.348 (61/201) |
5.40E-24 |
MST-1 protein kinase (STK4)
|
|
27.273 (72/264) |
1.59E-23 |
Serine/threonine-protein kinase 26 (STK26)
|
|
28.467 (78/274) |
1.88E-23 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
30.583 (63/206) |
1.99E-23 |
ERK activator kinase 2 (MEK2)
|
|
31.169 (72/231) |
2.34E-23 |
Serine/threonine-protein kinase 3 (STK3)
|
|
28.030 (74/264) |
2.93E-23 |
ERK activator kinase 1 (MEK1)
|
|
30.303 (70/231) |
1.47E-22 |
Doublecortin-like kinase 3 (DCLK3)
|
|
28.780 (59/205) |
2.13E-22 |
NIMA-related kinase 1 (NEK1)
|
|
29.703 (60/202) |
2.48E-22 |
Cyclin-dependent kinase 1 (CDK1)
|
|
30.516 (65/213) |
3.69E-22 |
Salt-inducible kinase 1 (SIK1)
|
|
29.682 (84/283) |
2.67E-21 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
29.682 (84/283) |
3.10E-21 |
Cyclin-dependent kinase 3 (CDK3)
|
|
29.524 (62/210) |
4.56E-21 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
30.303 (60/198) |
6.37E-21 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
30.732 (63/205) |
7.89E-21 |
Cyclin-dependent kinase 2 (CDK2)
|
|
28.502 (59/207) |
8.70E-21 |
Salt-inducible kinase 2 (SIK2)
|
|
27.365 (81/296) |
1.39E-20 |
Fused homolog (STK36)
|
|
30.097 (62/206) |
1.55E-20 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
30.846 (62/201) |
1.83E-20 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
27.315 (59/216) |
2.75E-20 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
30.392 (62/204) |
2.75E-20 |
NIMA-related kinase 6 (NEK6)
|
|
28.302 (60/212) |
2.95E-20 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
25.392 (81/319) |
6.23E-20 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
26.667 (64/240) |
1.06E-19 |
PAK-2 protein kinase (PAK2)
|
|
28.636 (63/220) |
1.11E-19 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
28.500 (57/200) |
1.45E-19 |
Serine/threonine-protein kinase 10 (STK10)
|
|
29.442 (58/197) |
1.46E-19 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
30.667 (69/225) |
1.65E-19 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
27.311 (65/238) |
1.66E-19 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
30.769 (68/221) |
1.83E-19 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
27.670 (57/206) |
1.93E-19 |
Aurora kinase C (AURKC)
|
|
30.144 (63/209) |
2.21E-19 |
NIMA-related kinase 7 (NEK7)
|
|
27.358 (58/212) |
2.56E-19 |
Misshapen-like kinase 1 (MINK1)
|
|
27.103 (58/214) |
2.86E-19 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
25.830 (70/271) |
2.97E-19 |
Aurora kinase A (AURKA)
|
|
28.019 (58/207) |
3.42E-19 |
Cyclin-dependent kinase 7 (CDK7)
|
|
28.631 (69/241) |
3.48E-19 |
PAK-1 protein kinase (PAK1)
|
|
28.571 (60/210) |
3.52E-19 |
Oxidative stress responsive 1 (OXSR1)
|
|
30.374 (65/214) |
3.86E-19 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
30.208 (58/192) |
5.10E-19 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
27.124 (83/306) |
5.26E-19 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
28.814 (68/236) |
5.74E-19 |
Polo-like kinase 4 (PLK4)
|
|
26.667 (64/240) |
6.00E-19 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
30.603 (71/232) |
8.39E-19 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
29.279 (65/222) |
8.43E-19 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
28.636 (63/220) |
9.09E-19 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
27.014 (57/211) |
1.01E-18 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
24.806 (64/258) |
1.01E-18 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
26.794 (56/209) |
1.09E-18 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
28.019 (58/207) |
1.20E-18 |
MEK kinase kinase 4 (MAP4K4)
|
|
27.751 (58/209) |
1.83E-18 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
28.070 (64/228) |
2.12E-18 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
27.805 (57/205) |
2.67E-18 |
Cyclin-dependent kinase 10 (CDK10)
|
|
32.407 (70/216) |
2.70E-18 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
29.880 (75/251) |
2.83E-18 |
Unc-51 like kinase 3 (ULK3)
|
|
25.490 (78/306) |
4.00E-18 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
28.470 (80/281) |
4.22E-18 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
28.780 (59/205) |
4.43E-18 |
NIMA-related kinase 2 (NEK2)
|
|
27.397 (60/219) |
5.61E-18 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
33.166 (66/199) |
5.89E-18 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
29.000 (58/200) |
6.58E-18 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
26.852 (58/216) |
7.32E-18 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
28.017 (65/232) |
8.67E-18 |
Protein kinase D (PRKD1)
|
|
30.208 (58/192) |
1.14E-17 |
PAK-4 protein kinase (PAK4)
|
|
28.125 (54/192) |
1.26E-17 |
Cyclin-dependent kinase 4 (CDK4)
|
|
31.905 (67/210) |
1.32E-17 |
SIK family kinase 3 (SIK3)
|
|
25.818 (71/275) |
1.48E-17 |
STE20-related kinase adapter protein beta (STRADB)
|
|
29.310 (68/232) |
1.58E-17 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
28.992 (69/238) |
1.63E-17 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
29.353 (59/201) |
1.71E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
26.596 (75/282) |
1.75E-17 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
28.571 (56/196) |
1.77E-17 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
29.412 (60/204) |
2.08E-17 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
26.087 (54/207) |
2.30E-17 |
Doublecortin-like kinase 1 (DCLK1)
|
|
27.805 (57/205) |
3.09E-17 |
Myosin-IIIb (MYO3B)
|
|
30.516 (65/213) |
3.10E-17 |
Omphalocele kinase 1 (NUAK1)
|
|
27.861 (56/201) |
3.42E-17 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
32.000 (64/200) |
4.27E-17 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
28.745 (71/247) |
7.34E-17 |
Protein kinase C theta (PRKCQ)
|
|
26.341 (54/205) |
8.12E-17 |
Ste-20-related kinase (STK39)
|
|
29.439 (63/214) |
8.86E-17 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
26.887 (57/212) |
1.09E-16 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
25.106 (59/235) |
1.37E-16 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
29.268 (60/205) |
1.42E-16 |
Cyclin-dependent kinase 5 (CDK5)
|
|
28.934 (57/197) |
1.49E-16 |
Myosin light kinase (MYLK)
|
|
25.000 (54/216) |
1.61E-16 |
ERK activator kinase 5 (MAP2K5)
|
|
25.581 (66/258) |
1.77E-16 |
Serine/threonine-protein kinase NLK (NLK)
|
|
29.756 (61/205) |
1.87E-16 |
Myosin light chain kinase 3 (MYLK3)
|
|
24.422 (74/303) |
2.10E-16 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
25.728 (53/206) |
2.23E-16 |
Doublecortin-like kinase 2 (DCLK2)
|
|
27.404 (57/208) |
2.78E-16 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
27.273 (54/198) |
2.98E-16 |
Activin receptor type IIA (ACVR2A)
|
|
32.258 (60/186) |
3.12E-16 |
Myosin-IIIa (MYO3A)
|
|
29.245 (62/212) |
3.46E-16 |
Aurora kinase B (AURKB)
|
|
24.254 (65/268) |
3.50E-16 |
Wee1-like protein kinase (WEE1)
|
|
28.959 (64/221) |
4.68E-16 |
Death-associated protein kinase 3 (DAPK3)
|
|
27.751 (58/209) |
6.70E-16 |
Serine/threonine-protein kinase MAK (MAK)
|
|
25.225 (56/222) |
7.74E-16 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
27.363 (55/201) |
7.88E-16 |
Cyclin-dependent kinase 6 (CDK6)
|
|
28.390 (67/236) |
1.07E-15 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
25.701 (55/214) |
1.12E-15 |
Polo-like kinase 2 (PLK2)
|
|
27.670 (57/206) |
1.16E-15 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
25.703 (64/249) |
1.17E-15 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
28.365 (59/208) |
1.21E-15 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
27.854 (61/219) |
1.25E-15 |
TAO kinase 1 (TAOK1)
|
|
26.007 (71/273) |
1.32E-15 |
Cyclin-dependent kinase 14 (CDK14)
|
|
28.638 (61/213) |
1.39E-15 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
23.881 (48/201) |
1.50E-15 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
31.034 (63/203) |
1.51E-15 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
24.038 (50/208) |
1.58E-15 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
26.633 (53/199) |
1.84E-15 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
28.302 (60/212) |
2.06E-15 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
25.234 (54/214) |
2.09E-15 |
BR serine/threonine kinase 1 (BRSK1)
|
|
25.912 (71/274) |
2.54E-15 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
30.928 (60/194) |
3.02E-15 |
Cyclin-dependent kinase 13 (CDK13)
|
|
26.267 (57/217) |
3.18E-15 |
Death-associated protein kinase 1 (DAPK1)
|
|
28.436 (60/211) |
3.22E-15 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
26.238 (53/202) |
4.40E-15 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
25.703 (64/249) |
5.24E-15 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
26.471 (54/204) |
5.37E-15 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
28.169 (60/213) |
5.39E-15 |
Cyclin-dependent kinase 9 (CDK9)
|
|
25.229 (55/218) |
5.45E-15 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
28.095 (59/210) |
6.46E-15 |
Peripheral plasma membrane protein CASK (CASK)
|
|
28.436 (60/211) |
6.97E-15 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
26.866 (72/268) |
8.19E-15 |
Protein kinase C iota (PRKCI)
|
|
28.216 (68/241) |
8.86E-15 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
29.091 (64/220) |
1.09E-14 |
Cyclin-dependent kinase 12 (CDK12)
|
|
24.885 (54/217) |
1.11E-14 |
Bone morphogenetic protein receptor (BMPR2)
|
|
30.116 (78/259) |
1.17E-14 |
BR serine/threonine kinase 2 (BRSK2)
|
|
30.303 (50/165) |
1.37E-14 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
27.863 (73/262) |
1.44E-14 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
25.828 (78/302) |
1.53E-14 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
28.910 (61/211) |
1.56E-14 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
23.789 (54/227) |
1.68E-14 |
Membrane-associated kinase (PKMYT1)
|
|
29.612 (61/206) |
1.97E-14 |
Cyclin-dependent kinase 15 (CDK15)
|
|
28.079 (57/203) |
2.03E-14 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
27.523 (60/218) |
2.04E-14 |
Serine/threonine-protein kinase 33 (STK33)
|
|
26.087 (42/161) |
2.21E-14 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
27.778 (60/216) |
2.40E-14 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
25.837 (54/209) |
2.57E-14 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
26.961 (55/204) |
2.99E-14 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
29.187 (61/209) |
3.00E-14 |
Cyclin-dependent kinase 16 (CDK16)
|
|
26.201 (60/229) |
3.22E-14 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
23.843 (67/281) |
3.24E-14 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
24.638 (51/207) |
3.50E-14 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
27.451 (56/204) |
3.53E-14 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
27.313 (62/227) |
3.98E-14 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
25.980 (53/204) |
4.17E-14 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
24.883 (53/213) |
5.32E-14 |
Activin receptor type IIB (ACVR2B)
|
|
30.412 (59/194) |
5.91E-14 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
30.508 (54/177) |
6.11E-14 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
28.372 (61/215) |
7.14E-14 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
26.961 (55/204) |
7.15E-14 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
27.854 (61/219) |
7.66E-14 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
27.536 (76/276) |
8.32E-14 |
Myosin light chain kinase 2 (MYLK2)
|
|
25.000 (50/200) |
8.46E-14 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
27.542 (65/236) |
9.12E-14 |
Protein kinase G1 (PRKG1)
|
|
26.794 (56/209) |
9.88E-14 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
30.435 (63/207) |
1.01E-13 |
Death-associated protein kinase 2 (DAPK2)
|
|
26.887 (57/212) |
1.45E-13 |
Cyclin-dependent kinase 17 (CDK17)
|
|
27.700 (59/213) |
1.49E-13 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
34.586 (46/133) |
1.54E-13 |
Activin receptor type IB (ACVR1B)
|
|
33.023 (71/215) |
1.66E-13 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
25.980 (53/204) |
1.70E-13 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
25.500 (51/200) |
1.88E-13 |
Checkpoint kinase-1 (CHK1)
|
|
27.941 (57/204) |
1.89E-13 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
27.586 (64/232) |
2.16E-13 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
28.372 (61/215) |
2.46E-13 |
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
30.435 (63/207) |
3.19E-13 |
TGF-beta receptor type I (TGFBR1)
|
|
30.047 (64/213) |
3.58E-13 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
26.180 (61/233) |
4.02E-13 |
Wee1-like protein kinase 2 (WEE2)
|
|
27.755 (68/245) |
4.17E-13 |
Protein kinase C alpha (PRKCA)
|
|
24.554 (55/224) |
4.87E-13 |
TAO kinase 3 (TAOK3)
|
|
28.922 (59/204) |
5.16E-13 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
29.767 (64/215) |
5.96E-13 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
26.690 (75/281) |
6.81E-13 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
27.941 (57/204) |
6.93E-13 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
25.234 (54/214) |
9.91E-13 |
Protein kinase C delta (PRKCD)
|
|
25.726 (62/241) |
1.21E-12 |
Nik-related protein kinase (NRK)
|
|
25.210 (60/238) |
1.48E-12 |
Cyclin-dependent kinase 18 (CDK18)
|
|
25.439 (58/228) |
1.91E-12 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
28.708 (60/209) |
2.08E-12 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
27.536 (57/207) |
2.73E-12 |
Serine/threonine-protein kinase 35 (STK35)
|
|
29.353 (59/201) |
2.89E-12 |
Casein kinase II alpha (CSNK2A1)
|
|
27.727 (61/220) |
2.99E-12 |
Polo-like kinase 1 (PLK1)
|
|
26.154 (51/195) |
3.18E-12 |
Protein kinase C zeta (PRKCZ)
|
|
25.862 (60/232) |
3.75E-12 |
Protein kinase C eta type (PRKCH)
|
|
25.439 (58/228) |
4.14E-12 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
26.887 (57/212) |
4.75E-12 |
Stress-activated protein kinase 2b (p38 beta)
|
|
28.000 (56/200) |
5.07E-12 |
Myotonin-protein kinase (DMPK)
|
|
32.275 (61/189) |
5.77E-12 |
Rho-associated protein kinase 1 (ROCK1)
|
|
27.556 (62/225) |
5.94E-12 |
TGF-beta-stimulated factor 1 (STK16)
|
|
30.144 (63/209) |
5.96E-12 |
PDZ binding kinase (PBK)
|
|
28.659 (47/164) |
6.39E-12 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
27.727 (61/220) |
6.67E-12 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
27.273 (66/242) |
6.68E-12 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
27.461 (53/193) |
6.68E-12 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
25.532 (60/235) |
9.07E-12 |
Protein kinase C beta (PRKCB)
|
|
25.728 (53/206) |
9.97E-12 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
26.316 (55/209) |
1.07E-11 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
29.448 (48/163) |
1.25E-11 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
26.941 (59/219) |
1.32E-11 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
22.115 (46/208) |
1.44E-11 |
Cyclin-dependent kinase 20 (CDK20)
|
|
25.000 (53/212) |
1.45E-11 |
Rho-associated protein kinase 2 (ROCK2)
|
|
27.143 (57/210) |
1.63E-11 |
Protein kinase C epsilon (PRKCE)
|
|
24.280 (59/243) |
1.76E-11 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
26.442 (55/208) |
2.03E-11 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
23.200 (58/250) |
2.46E-11 |
Cyclin-dependent kinase 19 (CDK19)
|
|
27.966 (66/236) |
2.80E-11 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
22.176 (53/239) |
4.27E-11 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
29.412 (50/170) |
4.38E-11 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
24.658 (72/292) |
5.03E-11 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
26.570 (55/207) |
5.74E-11 |
Obscurin (OBSCN)
|
|
26.154 (51/195) |
8.64E-11 |
Serine/threonine-protein kinase cot (COT)
|
|
26.724 (62/232) |
8.65E-11 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
27.108 (45/166) |
8.70E-11 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.762 (52/210) |
1.14E-10 |
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
25.668 (48/187) |
1.34E-10 |
Protein kinase N3 (PKN3)
|
|
27.823 (69/248) |
1.46E-10 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
29.762 (50/168) |
1.56E-10 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
26.667 (60/225) |
1.64E-10 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
24.286 (51/210) |
1.77E-10 |
MAP kinase p38 (MAPK12)
|
|
28.750 (46/160) |
2.47E-10 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
28.571 (46/161) |
2.50E-10 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
24.303 (61/251) |
3.15E-10 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
27.933 (50/179) |
3.48E-10 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
27.895 (53/190) |
3.63E-10 |
ERK activator kinase 7 (MAP2K7)
|
|
26.540 (56/211) |
3.90E-10 |
Protein kinase C gamma (PRKCG)
|
|
28.030 (37/132) |
4.44E-10 |
CaM-kinase IV kinase (CAMKK1)
|
|
26.316 (45/171) |
5.14E-10 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
31.928 (53/166) |
5.97E-10 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
27.391 (63/230) |
6.14E-10 |
Protein kinase N2 (PKN2)
|
|
26.087 (54/207) |
6.20E-10 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
27.439 (45/164) |
6.49E-10 |
Cyclin-dependent kinase 8 (CDK8)
|
|
26.939 (66/245) |
6.94E-10 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
28.049 (46/164) |
7.20E-10 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
27.933 (50/179) |
7.51E-10 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
25.926 (42/162) |
7.67E-10 |
Rhodopsin kinase GRK1 (GRK1)
|
|
27.094 (55/203) |
9.97E-10 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
23.383 (47/201) |
1.11E-09 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
24.051 (57/237) |
1.26E-09 |
Yet another novel kinase 2 (STK32B)
|
|
26.540 (56/211) |
1.58E-09 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
27.545 (46/167) |
1.68E-09 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
27.488 (58/211) |
1.97E-09 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
24.155 (50/207) |
1.97E-09 |
Protein kinase G2 (PRKG2)
|
|
24.103 (47/195) |
3.25E-09 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
24.855 (43/173) |
4.13E-09 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
27.778 (45/162) |
4.88E-09 |
Casein kinase II alpha prime (CSNK2A2)
|
|
25.792 (57/221) |
5.98E-09 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
22.222 (46/207) |
6.15E-09 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
34.314 (35/102) |
6.30E-09 |
Cytoplasmic DRAK1 (STK17A)
|
|
24.706 (63/255) |
9.00E-09 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
36.000 (36/100) |
9.55E-09 |
Testis-specific serine kinase 2 (TSSK2)
|
|
22.449 (44/196) |
1.44E-08 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
25.837 (54/209) |
1.62E-08 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
23.853 (52/218) |
1.79E-08 |
Citron Rho-interacting kinase (CIT)
|
|
28.708 (60/209) |
1.93E-08 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
23.954 (63/263) |
2.28E-08 |
NDR2 protein kinase (STK38L)
|
|
21.008 (50/238) |
2.36E-08 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
23.558 (49/208) |
2.77E-08 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
27.411 (54/197) |
3.70E-08 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
28.571 (56/196) |
4.99E-08 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
29.915 (35/117) |
6.31E-08 |
NDR1 protein kinase (STK38)
|
|
21.008 (50/238) |
6.54E-08 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
22.420 (63/281) |
9.98E-08 |
Protein kinase N1 (PKN1)
|
|
27.488 (58/211) |
3.03E-07 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
24.599 (46/187) |
4.75E-07 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
25.116 (54/215) |
6.76E-07 |
Casein kinase I epsilon (CSNK1E)
|
|
22.500 (45/200) |
9.52E-07 |
Tau-tubulin kinase (TTBK1)
|
|
19.557 (53/271) |
1.30E-06 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
28.676 (39/136) |
3.22E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
22.430 (48/214) |
5.73E-06 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
22.222 (48/216) |
6.44E-06 |
MAPK signal-integrating kinase 1 (MKNK1)
|
|
19.124 (48/251) |
6.89E-06 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
26.020 (51/196) |
8.09E-06 |
Casein kinase I delta (CSNK1D)
|
|
22.222 (44/198) |
8.33E-06 |
Casein kinase I gamma-2 (CSNK1G2)
|
|
22.857 (56/245) |
9.66E-06 |
Rhodopsin kinase GRK7 (GRK7)
|
|
25.118 (53/211) |
1.09E-05 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
24.402 (51/209) |
1.65E-05 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
21.318 (55/258) |
2.01E-05 |
NF-kappa-B-activating kinase (TBK1)
|
|
22.439 (46/205) |
2.44E-05 |
Casein kinase I gamma-1 (CSNK1G1)
|
|
21.739 (45/207) |
3.77E-05 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
24.766 (53/214) |
4.89E-05 |
Casein kinase I gamma-3 (CSNK1G3)
|
|
21.463 (44/205) |
5.58E-05 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
24.000 (54/225) |
5.67E-05 |
Triple functional domain protein (TRIO)
|
|
23.590 (46/195) |
6.44E-05 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
24.155 (50/207) |
6.86E-05 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
29.560 (47/159) |
9.96E-05 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
24.201 (53/219) |
1.03E-04 |
Large tumor suppressor homolog 2 (LATS2)
|
|
19.850 (53/267) |
1.34E-04 |
Extracellular tyrosine-protein kinase PKDCC (PKDCC)
|
|
28.244 (37/131) |
1.59E-04 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
23.077 (48/208) |
2.22E-04 |
Tau-tubulin kinase 2 (TTBK2)
|
|
22.727 (45/198) |
3.59E-04 |
Serine/threonine-protein kinase 40 (STK40)
|
|
25.641 (30/117) |
3.80E-04 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
26.829 (44/164) |
7.51E-04 |
Serine/threonine-protein kinase 31 (STK31)
|
|
25.781 (33/128) |
7.55E-04 |
Titin (TTN)
|
21.782 (44/202) |
1.00E-03 |
Kalirin (KALRN)
|
|
23.590 (46/195) |
2.00E-03 |
Sugen kinase 110 (SBK3)
|
|
28.889 (39/135) |
2.00E-03 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
24.390 (50/205) |
5.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |